Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zedula Special Drug Use Observational Study in Ovarian Cancer
jRCT2031210289Completed
- Sponsor
- Takeda
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of niraparib in ovarian cancer, sponsored by Takeda. Primary endpoints: Number of participants with adverse event of myelosuppression, Number of participants with adverse event of hypertension and 4 more. Started Sep 2021; status: completed.
02
Drugs
niraparib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on jRCT2031210289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210289.